Insmed Incorporated
Records under this name other than the patents Insmed Incorporated holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 56 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,718,189 | Sustained Release of Antiinfectives Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 12,104,186 | Deimmunized Lysostaphin and Methods of Use Formerly held In force · High confidence | In force | High confidence | |
| US 12,410,246 | ANTI-STEM CELL FACTOR ANTIBODIES AND METHODS OF BLOCKING THE INTERACTION BETWEEN SCF AND c-KIT Formerly held In force · High confidence | In force | High confidence | |
| US 7,879,351 | High Delivery Rates for Lipid Based Drug Formulations, and Methods of Treatment Thereof Term ended Ended no later than Nov 17, 2026 · Medium confidence | Term ended | Ended no later than Nov 17, 2026 | Medium confidence |
| US 7,968,679 | Purified RHLGF-I/RHLGFBP-3 Complexes and Their Method of Manufacture Term ended Term ended Jan 16, 2026 · High confidence | Term ended | Term ended Jan 16, 2026 | High confidence |
| US 9,186,322 | Platinum Aggregates and Process for Producing the Same Term ended Term ended Sep 6, 2025 · High confidence | Term ended | Term ended Sep 6, 2025 | High confidence |
| US 11,071,769 | Lipo-Glycopeptide Cleavable Derivatives and Uses Thereof Lapsed on the fee record Ended Jul 27, 2025 · High confidence | Lapsed on the fee record | Ended Jul 27, 2025 | High confidence |
| US 7,544,369 | Sustained Release of Antiinfectives Term ended Term ended Jun 6, 2025 · High confidence | Term ended | Term ended Jun 6, 2025 | High confidence |
| US 7,354,994 | Recombinant Igf Expression Systems Term ended Term ended Jun 1, 2025 · High confidence | Term ended | Term ended Jun 1, 2025 | High confidence |
| US 8,802,137 | Sustained Release of Antiinfectives Term ended Term ended Apr 8, 2024 · Medium confidence | Term ended | Term ended Apr 8, 2024 | Medium confidence |